Literature DB >> 35017393

First 100 minimally invasive liver resections in a new tertiary referral centre for liver surgery.

Giuliano La Barba1, Leonardo Solaini2, Giorgia Radi1, Maria Teresa Mirarchi1, Fabrizio D'Acapito1, Andrea Gardini1, Alessandro Cucchetti2, Giorgio Ercolani2.   

Abstract

BACKGROUND: In the last decades, there has been an exponential diffusion of minimally invasive liver surgery (MILS) worldwide. The aim of this study was to evaluate our initial experience of 100 patients undergoing MILS resection comparing their outcomes with the standard open procedures.
MATERIALS AND METHODS: One hundred consecutive MILS from 2016 to 2019 were included. Clinicopathological data were reviewed to evaluate outcomes. Standard open resections were used as the control group and compared exploiting propensity score matching.
RESULTS: In total, 290 patients were included. The rate of MILS has been constantly increasing throughout years, representing the 48% in 2019. Of 100 (34.5%) MILS patients, 85 could be matched. After matching, the MILS conversion rate was 5.8% (n = 5). The post-operative complication rates were higher in the open group (45.9% vs. 31.8%, P = 0.004). Post-operative blood transfusions were less common in the MILS group (4.7% vs. 16.5%, P = 0.021). Biliary leak occurred in 2 (2.4) MILS versus 13 (15.3) open. The median comprehensive complication index was higher in the open group (8.7 [0-28.6] vs. 0 [0-10.4], P = 0.0009). The post-operative length of hospital stay was shorter after MILS (median 6 [5-8] vs 8 [7-13] days, P < 0.0001).
CONCLUSIONS: The rate of MILS has been significantly increasing throughout the years. The benefits of MILS over the traditional open approach were confirmed. The main advantages include lower rates of post-operative complications, blood transfusions, bile leaks and a significantly decreased hospital stay.

Entities:  

Keywords:  Laparoscopic liver resection; minimally invasive surgery; tertiary centre

Year:  2022        PMID: 35017393      PMCID: PMC8830570          DOI: 10.4103/jmas.JMAS_310_20

Source DB:  PubMed          Journal:  J Minim Access Surg        ISSN: 1998-3921            Impact factor:   1.407


INTRODUCTION

Minimally invasive liver surgery (MILS) has grown exponentially worldwide in the last decades.[12] The laparoscopic approach in liver surgery has been one of the major advances in surgery in recent years.[3] Recently, several systematic reviews on laparoscopic liver resection (LLR) demonstrated fewer complications rate, decreased blood loss and transfusion rate, and a shorter hospital stay in the LLR group when compared to open liver resections and with comparable oncological outcomes.[245 67] However, the increase of laparoscopic approach for liver surgery is not homogeneous worldwide. At the same time, the relationship between outcome and hospital volume in digestive cancer surgery has been investigated.[89] El Amrani et al. have recently determined the minimal number of procedures required to define a high-volume hospital. Based on these results, the authors noted that post-operative mortality in digestive cancer surgery was lower in high-volume hospitals. In addition, they showed that the benefits of high volumes were transferable across procedures. They proposed a new minimal cut-off for several surgical procedures, setting in 76 resections per year to perform liver surgery.[8] In liver surgery, the association between the hospital volume and the operative outcome has been largely explored.[1011] These data prompted that these procedures should be centralised in high-volume hospitals to reduce post-operative mortality and improve survival outcomes. Recent literature aimed to define a minimum number of annual resections to be carried out to identify those centres that should perform this type of surgery. These are defined as reference centres.[8] In 2016, a regional re-organisation of our health system identified our centre as the HPB hub of our catchment area. In particular, four trusts representing 1.300.000 inhabitants/72 municipalities, were united in the 'Romagna health trust'. After the first 4 years of activity, we performed an audit on our results to continue a path of improvement. The aim of this study was to evaluate the clinical outcomes of our first 100 MILS performed in a new referral centre for Hepato-Pancreatico-Biliary (HPB) surgery in Italy. In doing so, we exploited our database on liver resections, using the standard open resections as a control group to verify the outcomes.

MATERIALS AND METHODS

This study was performed according to the Strengthening the Reporting of Cohort Studies in Surgery.[12] Data were extracted by an Institutional Review Board-approved retrospective database.

Design and patients

All consecutive patients who underwent hepatic resection (minimally invasive or open) between January 1, 2016, and January 1, 2020, were screened for inclusion. Patients were excluded if they had a biliary reconstruction and if no resections were performed. Patients were grouped as per the method of surgery: MILS or open. All patients were evaluated preoperatively for the laparoscopic approach. Performance status, tumour size and location were evaluated in the process of selecting those patients eligible for laparoscopy.

Variables and definitions

Collected outcomes were procedure type (open, MILS), conversion to open surgery, operative time (minutes), intra-operative blood transfusions, synchronous colo-rectal resection, overall complications, and major complications, length of hospital stay (days), in-hospital mortality. Complications, readmissions and mortality were all collected up to patient's discharge. Post-operative complications were graded with the classification proposed by Dindo et al.[13] Liver failure was defined, according to the International Study Group of Liver Surgery classification, as any alteration of international normalised ratio and bilirubin values after post-operative day 5.[14] The comprehensive complication index (CCI) was used to calculate the grade of severity and number of post-operative complications.[1516]

Matching

To minimise the impact of treatment allocation bias, laparoscopic resections were matched to open resections exploiting propensity scores. Multivariable logistic regression was performed to estimate the propensity to undergo laparoscopic resection for all patients, regardless of the actual treatment received. Propensity scores were based on predictors of treatment or on those baseline variables which differed with a P = 0.05. In this analysis, the calculation of the propensity scores was based on the type of tumour (malignant versus benign) and the number of nodules (≥3 vs. <3). Nearest neighbour matching was performed in a 1:1 ratio without replacement and with a calipre width of 0.2 standard deviation.

Statistical analyses

Data were analysed using IBM SPSS Statistics for Windows version 24.0 (IBM Corp., Armonk, NY, USA) and R Statistical Software version i386 3.3.3 (Foundation for Statistical Computing, Vienna, Austria). Analyses were performed according to the intention-to-treat principle. Before matching continuous variables were presented as median and interquartile range and were compared using the Mann–Whitney U-test. Categorical data were presented as frequencies with percentages and were compared using the Chi-square or Fisher's exact test, as appropriate. In the post-match analyses, the Wilcoxon signed-rank test was used to compare continuous variables while McNemar's test was used for categorical data. In the matched cohort logistic regression was used to calculate the odds ratio (OR) for post-operative complications of perioperative variables (age, American Statistical Association (ASA) score, nodule size, number of nodules, malignant tumour, laparoscopic approach, synchronous resections and intra-operative transfusions). All variables showing P < 0.05 were included in a multivariate analysis performed in stepwise manner.

RESULTS

Total cohort

In total, 356 patients were screened, of whom 66 were excluded for reasons [Figure 1], leaving 290 patients for analysis.
Figure 1

Flowchart summarizing the patients and the propensity score matching

Flowchart summarizing the patients and the propensity score matching The rate of MILS has been constantly increasing throughout the years, representing the 48% in 2019 [Figure 2]. The MILS procedures, which included 12 robotic liver resections, were grouped according to Kawaguchi's difficulty score[17] in [Table 1]. There was no differences with regards to the complexity of the procedure (Group 1 n = 19, 76% Group 2 3, 12% Group 3 3, 12% vs, 55, 73%; 14, 19%; 6, 8%; P = 0.656) and the complications rates (overall n = 4, 16% vs. 8, 11%; P = 0.444 – Clavien-Dindo >2 2, 8% vs. 6, 8%; P = 0.488) between the MILS procedure performed during the first (2016–2017) and the second interval (2018–2019) of the study period.
Figure 2

Trend of the Minimally Invasive Liver Surgery rate per year

Table 1

Minimally invasive liver surgery procedures grouped according to the Kawaguchi’s difficulty score

n
Group 1 (wedge resection and left lateral sectionectomy)74
Group 2 (anterolateral segmentectomy and left hepatectomy)17
Group 3 (postero-superior segmentectomy, right posterior sectionectomy, right hepatectomy, central hepatectomy, and extended left/right hepatectomy)9
Trend of the Minimally Invasive Liver Surgery rate per year Minimally invasive liver surgery procedures grouped according to the Kawaguchi’s difficulty score Patients' characteristics grouped according to the approach are shown in Table 2. Liver status at operation was available only for 220 patients: there were 19 (14.1%) cases of liver cirrhosis in the MILS group versus 15 (21.4%) in the open group (P = 0.356). The diagnosis of malignancy was less common in the laparoscopic group (72.0 vs. 86.8%, P < 0.002). Three or more nodules were more commonly seen in the open group (7.0 vs. 32.6%, P = 0.00001). Intra-operative outcomes are shown in Table 3. Conversion from MILS to open occurred in five patients (5.0%). Major resections were more common in the open group (13.8, vs. 8.0%; P < 0.00001). The post-operative outcomes are shown in Table 4. Overall mortality was 0.7% (two patients in the open group). The overall complication rate was significantly higher after open liver resection (47.8% vs. 12.0%, P = 0.026). Bile leak was less often seen after MILS (2.0 vs. 10.0%, P = 0.015). Median CCI was higher after open liver resections (median 8.7 [0–26.2] vs. 0 [0–8.7] days, P = 0.0002). Post-operative length of hospital stay was shorter after MILS (median 6 [4-8] vs. 8 [7-13] days, P < 0.0001).
Table 2

Patients’ characteristics

VariablesTotal cohort P Matched cohort P


MILS (n=100), n (%)Open (n=190), n (%)MILS (n=85), n (%)Open (n=85), n (%)
Age>70
 Yes36 (36.0)67 (35.2)0.89830 (35.3)28 (36.9)0.868
 No64 (64.0)123 (64.8)55 (64.7)57 (67.1)
Female
 Yes50 (50.0)82 (43.1)0.32143 (50.6)42 (49.4)0.753
 No50 (50.0)108 (46.9)42 (49.4)43 (50.6)
ASA>2
 Yes45 (45.0)80 (42.1)0.70838 (44.7)34 (40.0)0.617
 No55 (55.0)110 (67.9)47 (55.3)51 (60.0)
Malignancy
 Yes72 (72.0)165 (86.8)0.00263 (74.1)63 (74.1)1.000
 No28 (28.0)25 (13.2)22 (25.9)22 (25.9)
Nodules≥3
 Yes7 (7.0)62 (32.6)<0.00016 (7.1)8 (9.4)1.000
 No83 (92.2)128 (67.4)79 (92.9)77 (90.6)
Tumor size (cm)
 <216 (16.0)38 (20)0.47016 (18.8)20 (23.5)0.785
 ≥2-<549 (49.0)76 (40)41 (48.2)36 (42.3)
 ≥531 (31.0)56 (29.4)28 (32.9)29 (34.1)
 NA4 (4.0)20 (10.6)
Neoadjuvant chemotherapy°
 Yes14 (29.8)45 (37.8)0.42710 (11.8)15 (17.6)0.332
 No33 (70.2)74 (62.2)75 (88.2)70 (82.3)

°Calculated only on metastases (n=47 in MILS vs. 119 in open). MILS: Minimally invasive liver surgery, NA: Not applicable ASA: American Society of Anaesthesiologists

Table 3

Intra-operative variables

VariablesTotal cohort P Matched cohort P


MILS (n=100), n (%)Open (n=190), n (%)MILS (n=85), n (%)Open (n=85), n (%)
Type of procedure
 Wedge resection47 (47.0)96 (50.5)<0.0000130 (35.3)23 (27.1)0.067
 Segmentectomy19 (19.0)45 (23.6)20 (23.5)26 (30.6)
 Right hepatectomy5 (5.0)15 (7.8)5 (5.9)8 (9.4)
 Left hepatectomy4 (3.0)11 (5.7)2 (2.3)6 (7.1)
 Right posterior sectionectomy4 (4.0)16 (8.4)4 (4.7)6 (7.1)
 Left lobectomy21 (21.0)7 (3.6)18 (20.0)6 (7.1)
Conversion to open
 Yes5 (5)5 (5.9)
 No95 (95)80 (94.1)
Syncronous resection
 Right colectomy5 (5.0)4 (2.1)0.0974 (4.7)1 (1.2)0.581
 Left colectomy1 (1.0)10 (5.2)05 (5.9)
 Anterior rectal resection2 (2.0)8 (4.2)1 (1.2)3 (3.6)
 Other1 (1.0)5 (2.6)
Operative time (min)
 Median (IQR)292 (195-380)306 (175-420)0.329266 (245-304)290 (263-309)0.942
Intraoperative blood trasfusion
 Yes3 (3)9 (4.7)0.5543 (3.6)4 (4.7)0.726
 No97 (97)181 (95.3)82 (96.7)81 (95.3)

MILS: Minimally invasive liver surgery, IQR: Interquartile range

Table 4

Post-operative outcomes

VariablesTotal cohortMatched cohort


MILS (n=100), n (%)Open (n=190), n (%) P MILS (n=85), n (%)Open (n=85), n (%) P
Post-operative complications
 Yes12 (12.0)91 (47.8)0.02627 (31.8)39 (45.9)0.004
 No88 (88.0)99 (52.2)58 (69.2)46 (54.1)
Clavien dindo Grade≥3
 Yes8 (8.0)25 (13.1)0.3199 (10.6)17 (20)0.124
 No92 (92.0)165 (86.9)76 (89.4)68 (80)
Mortality
 Yes02 (1.1)0.54601 (1.2)1.000
 No100 (100)188 (98.9)85 (100)84 (98.8)
Post-operative blood transfusion
 Yes5 (5.0)23 (12.1)0.0604 (4.7)14 (16.5)0.021
 No95 (95.0)167 (87.9)81 (95.3)71 (83.5)
Ascites
 Yes2 (2.0)11 (5.7)0.2312 (2.4)7 (8.2)0.180
 No98 (98.0)179 (94.3)83 (97.6)78 (91.8)
Liver failure
 Yes02 (1.0)0.54501 (1.2)0.500
 No100 (100)187 (98.4)85 (100)84 (98.8)
Subphrenic abscess
 Yes5 (5.0)15 (7.8)0.6215 (5.9)9 (10.6)0.065
 No85 (85.0)174 (92.2)80 (94.1)76 (89.4)
Biliary fistula
 Yes2 (2.0)19 (10)0.0152 (2.4)13 (15.3)0.007
 No98 (98.0)170 (90)83 (97.6)72 (84.7)
CCI
 Median (IQR)0 (0-8.7)8.7 (0-26.2)0.00020 (0-10.4)8.7 (0-28.6)0.0009
Length of hospital stay
 Median (IQR)6 (4-8)8 (7-13)<0.00016 (5-8)8 (7-13)<0.0001

MILS: Minimally invasive liver surgery, IQR: Interquartile range, CCI: Comprehensive complication index

Patients’ characteristics °Calculated only on metastases (n=47 in MILS vs. 119 in open). MILS: Minimally invasive liver surgery, NA: Not applicable ASA: American Society of Anaesthesiologists Intra-operative variables MILS: Minimally invasive liver surgery, IQR: Interquartile range Post-operative outcomes MILS: Minimally invasive liver surgery, IQR: Interquartile range, CCI: Comprehensive complication index

Matched cohort

Of all MILS, 94.4% could be matched successfully to an open control. Differences (P < 0.05) in baseline characteristics were no longer present after matching. Intra-operative outcomes are presented in Table 2. Conversion from to open liver resection occurred in five patients (5.8%). Post-operative outcomes are shown in Table 3. The post-operative complication rates were higher in the open group (45.9% vs. 31.8%, P = 0.004). Post-operative blood transfusions were less common in the MILS group (4.7% vs. 16.5%, P = 0.021). Biliary leak occurred in 2 (2.4) MILS vs. 13 (15.3) open. The median CCI was significantly higher in the open group (8.7 [0–28.6] vs. 0 [0–10.4], P = 0.0009). The post-operative length of hospital stay was shorter after MILS [median 6 (5–8) vs 8 (7–13) days, P < 0.0001]. The multivariable analysis showed that synchronous resections (8.21, 1.73–38.0; P = 0.008) and MILS (0.49, 0.25–0.95; P = 0.036) were factors influencing the post-operative complications rate.

DISCUSSION

The advances in techniques and technology have allowed the spreading of the laparoscopic approach over the last three decades and its employ even in complex surgical procedures. Considering its complexity, the centralisation of patients who need liver surgery deemed necessary. There is a strong evidence that complex surgical procedures performed in high-volume tertiary centres for digestive cancer surgery as a part of multidisciplinary teams are associated with lower mortality risk.[81118] In this context, our early experience has shown that MILS in a 'young' HPB center could be associated with adequate safety parameters while maintaining the benefits of minimally invasive surgery. This was also associated with a rate of complex procedure which was in line with that of large multicentre series.[19] To validate our results we performed a propensity score match comparison with the standard open resections performed in the same study period confirming that MILS was associated with improved post-operative outcomes. These included mortality and overall post-operative complications, the rate of biliary fistula and the need of blood transfusions after surgery. Similar findings were shown by a recent meta-analysis by Jin et al.;[5] those authors, analysing eight randomised controlled trials with a total of 554 patients, found that laparoscopy was associated with lower complication rates than open surgery. This was also confirmed by logistic regression analysis in which the open approach and synchronous resections were found to be risk factors for complications. This is a recurrent finding in liver surgery literature. As such, a recent analysis by Wang et al.[20] found that the incidence of severe complications was doubled after synchronous resection (26.7%) when compared with the delayed liver resections (11.2%). In our series, complication rates were higher than those set by Rössler 2016 et al. in their benchmark analysis.[21] This could be explained by the fact that our series represent a population of patients in which more than 40% were ASA >2 and this is in contrast with that reported by Rossler including only healthy living donors. As reported above, the biliary leak occurred less commonly after LLRs (2.4 vs. 15.3%) and this is consistent with what has been reported in literature. A recent study by Smith et al.[22] showed a bile leak rate of 2.8% after 1388 consecutive liver resections: the authors found that the minimally invasive approach significantly reduced the odd of bile leak with an OR of 0.48 (95% confidence interva 0.23–0.99). The conversions rate was 5.6% in the current series and this is in line with those reported in literature. In all 5 cases conversions were due to bulky tumours which is a well-established risk factor for conversion to open surgery.[232425] As expected, the length of hospital stay was significantly shorter after the laparoscopic approach. This may reflect the improved post-operative functional outcomes which have a major impact on the decision to discharge a patient. In addition, a shorter hospital stay significantly decrease total post-operative costs as suggested by Medbery et al.[26] who reported a $ 7000 savings in the laparoscopic group in their comparative analysis of right hepatectomies. Similar findings were found by Polignano et al.[27] who analysed the overall hospital costs after segmentectomies and found that it was significantly lower in the laparoscopic group by an average of 2,571 pounds sterling. In light of our results and of those reported by the most recent meta-analyses, we can support the use of the laparoscopic approach whenever technically feasible and oncologically appropriate. This study presents a few limitations. First, some of the included laparoscopic procedures may have been part of the learning curve of one of the surgeons performing these procedures as he was trained after our centre became an HPB hub. However, the impact of the learning curve may have been limited in the outcomes of the MILS group. This could be supported by the fact that the complication rate and the level of complexity of the laparoscopic procedures were similar between the first and the second period of the study interval. Second, this was a retrospective study and it could be affected by biases linked to its nature. In particular, patients' pre-operative clinical status was represented mostly by ASA score in this study and this might have been underestimated some characteristics which could have influenced the morbidity rate in the open group. The strengths of this study are linked to the short study interval which minimise the time-related differences in perioperative care and operative factors. In addition, the propensity score matching mitigated the impact of the treatment allocation bias which significantly affects the outcomes in retrospective studies.

CONCLUSIONS

Our analysis confirmed the benefits of laparoscopic liver surgery over the traditional open approach in expert centres. The main advantages include lower rates of post-operative complications, blood transfusions, bile leaks and a significantly decreased hospital stay. Synchronous resections remain the procedures with the greater risk of complications and should be performed with caution even in the laparoscopic approach.

Financial support and sponsorship

Nil.

Conflicts of interest

There are no conflicts of interest.
  27 in total

1.  Defining Benchmarks for Major Liver Surgery: A multicenter Analysis of 5202 Living Liver Donors.

Authors:  Fabian Rössler; Gonzalo Sapisochin; GiWon Song; Yu-Hung Lin; Mary Ann Simpson; Kiyoshi Hasegawa; Andrea Laurenzi; Santiago Sánchez Cabús; Milton Inostroza Nunez; Andrea Gatti; Magali Chahdi Beltrame; Ksenija Slankamenac; Paul D Greig; Sung-Gyu Lee; Chao-Long Chen; David R Grant; Elizabeth A Pomfret; Norihiro Kokudo; Daniel Cherqui; Kim M Olthoff; Abraham Shaked; Juan Carlos García-Valdecasas; Jan Lerut; Roberto I Troisi; Martin De Santibanes; Henrik Petrowsky; Milo A Puhan; Pierre-Alain Clavien
Journal:  Ann Surg       Date:  2016-09       Impact factor: 12.969

2.  The predictive value of postoperative clinical risk scores for outcome after hepatic resection: a validation analysis in 807 patients.

Authors:  Nuh N Rahbari; Christoph Reissfelder; Moritz Koch; Heike Elbers; Fabian Striebel; Markus W Büchler; Jürgen Weitz
Journal:  Ann Surg Oncol       Date:  2011-06-15       Impact factor: 5.344

Review 3.  Short- and long-term outcomes after laparoscopic and open hepatic resection: systematic review and meta-analysis.

Authors:  Reza Mirnezami; Alexander H Mirnezami; Kandiah Chandrakumaran; Mohammad Abu Hilal; Neil W Pearce; John N Primrose; Robert P Sutcliffe
Journal:  HPB (Oxford)       Date:  2011-03-02       Impact factor: 3.647

4.  The comprehensive complication index: a novel and more sensitive endpoint for assessing outcome and reducing sample size in randomized controlled trials.

Authors:  Ksenija Slankamenac; Nina Nederlof; Patrick Pessaux; Jeroen de Jonge; Bas P L Wijnhoven; Stefan Breitenstein; Christian E Oberkofler; Rolf Graf; Milo A Puhan; Pierre-Alain Clavien
Journal:  Ann Surg       Date:  2014-11       Impact factor: 12.969

Review 5.  Safety and efficacy for laparoscopic versus open hepatectomy: A meta-analysis.

Authors:  Bao Jin; Mei-Ting Chen; Yu-Tong Fei; Shun-da Du; Yi-Lei Mao
Journal:  Surg Oncol       Date:  2017-06-28       Impact factor: 3.279

6.  Difficulty of Laparoscopic Liver Resection: Proposal for a New Classification.

Authors:  Yoshikuni Kawaguchi; David Fuks; Norihiro Kokudo; Brice Gayet
Journal:  Ann Surg       Date:  2018-01       Impact factor: 12.969

7.  A novel difficulty scoring system for laparoscopic liver resection.

Authors:  Daisuke Ban; Minoru Tanabe; Hiromitsu Ito; Yuichiro Otsuka; Hiroyuki Nitta; Yuta Abe; Yasushi Hasegawa; Toshio Katagiri; Chisato Takagi; Osamu Itano; Hironori Kaneko; Go Wakabayashi
Journal:  J Hepatobiliary Pancreat Sci       Date:  2014-10       Impact factor: 7.027

8.  Case-matched analysis of totally laparoscopic versus open liver resection for HCC: short and middle term results.

Authors:  Luca Aldrighetti; Eleonora Guzzetti; Carlo Pulitanò; Federica Cipriani; Marco Catena; Michele Paganelli; Gianfranco Ferla
Journal:  J Surg Oncol       Date:  2010-07-01       Impact factor: 3.454

9.  Comparison and validation of three difficulty scoring systems in laparoscopic liver surgery: a retrospective analysis on 300 cases.

Authors:  Nadia Russolillo; Cecilia Maina; Francesco Fleres; Serena Langella; Roberto Lo Tesoriere; Alessandro Ferrero
Journal:  Surg Endosc       Date:  2020-01-16       Impact factor: 4.584

10.  Specificity of Procedure volume and its Association With Postoperative Mortality in Digestive Cancer Surgery: A Nationwide Study of 225,752 Patients.

Authors:  Mehdi El Amrani; Xavier Lenne; Guillaume Clement; Jean-Robert Delpero; Didier Theis; François-René Pruvot; Amelie Bruandet; Stephanie Truant
Journal:  Ann Surg       Date:  2019-11       Impact factor: 12.969

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.